NOVONIX Ltd

NOVONIX Limited announced its application to quote 171,591 new ordinary fully paid shares on the ASX. These shares are being issued as a result of the conversion of 273,855 employee performance rights, which vested on August 13, 2026. The new shares, valued at an estimated 0.15 AUD per security, will rank equally with existing shares from their issue date of August 14, 2026.

NOVONIX Limited announced a change in its American Depositary Share (ADS) ratio, moving from one ADS representing four ordinary shares to one ADS representing forty ordinary shares. This adjustment is equivalent to a one-for-ten reverse split of the existing ADSs and is expected to become effective on August 27, 2026. The primary purpose of this change is to increase the per-ADS trading price to help the company regain compliance with Nasdaq's minimum bid price requirement, as its ADSs had been trading below US$1.00 for 30 consecutive business days.

NOVONIX delivered a C-sample of synthetic graphite AAM to Panasonic Energy, which internal testing indicates meets specifications, pending formal validation. The company reaffirmed expected mass production for Panasonic in H2 2027. NOVONIX also secured a US$103 million tax credit for its Riverside project under the 48C program and successfully completed a A$20.7 million institutional placement and A$0.96 million share purchase plan. Additionally, NOVONIX divested its Battery Technology Solutions (BTS) division to focus on synthetic graphite production and announced a Board and CFO transition.

NOVONIX Ltd Director Sharan Burrow increased her direct shareholding by acquiring 31,250 ordinary shares on July 22, 2026. The shares were issued under a Share Purchase Plan for a consideration of $5,000. Following this transaction, Director Burrow now holds a total of 246,989 ordinary shares and 195,938 share rights in the company.

NOVONIX Limited successfully completed its Share Purchase Plan (SPP) offer, raising A$962,600 from eligible shareholders. The company issued 6,016,250 fully paid ordinary shares at A$0.16 per share, with approximately 89 shareholders participating. The funds will be utilized for capital expenditure to support production capacity and meet forecast customer demand. This SPP follows a previously completed A$20.7 million institutional placement.

NOVONIX Limited announced an updated timetable for its Share Purchase Plan (SPP), bringing forward the closing date to July 17, 2026, from the previously announced August 14, 2026. This revision follows the company's receipt of waivers from ASX Listing Rules. Applications and payments must be received by the revised closing date, with results expected around July 20, 2026, and shares allotted by July 22, 2026.

NOVONIX Limited announced that the ASX has granted waivers for Listing Rules 7.1 and 10.11, allowing the company to proceed with its Share Purchase Plan (SPP). These waivers permit NOVONIX to issue new shares at an Offer Price of $0.16, which is less than 80% of the 5-day volume weighted average price, without requiring shareholder approval. The waivers also allow directors to participate in the SPP, ensuring eligible shareholders can subscribe for shares at the same price as institutional investors.

NOVONIX Ltd announced the application for quotation of 34,824 new ordinary fully paid shares. These shares are being issued as a result of the conversion of 54,480 performance rights, which were part of an employee incentive scheme. The conversion took place on July 2, 2026, with the shares expected to be issued on July 3, 2026. Following this quotation, the total number of ordinary fully paid shares on issue will be 991,596,744.

NOVONIX Limited announced the remuneration arrangements for Ron Edmonds, who assumed the role of Interim Chief Financial Officer effective July 1, 2026. Mr. Edmonds will receive a pro-rated base salary of USD$450,000, along with potential short-term incentives up to 100% of his fixed remuneration and USD$95,000 in long-term share rights. During his interim CFO appointment, Mr. Edmonds has stepped aside as Chair, with Deputy Chair Admiral Robert Natter resuming the Chair role.

NOVONIX Ltd announced the cessation of 5,781,507 performance rights (ASX code NVXAD) on June 30, 2026. These rights lapsed because the conditional requirements were not met or became incapable of being satisfied, primarily due to the cessation of employment. The company did not pay any consideration for this cessation, resulting in 21,619,875 performance rights remaining unquoted.